LEAD PROGRAMME LIRAGLUTIDE EFFECT AND ACTION IN DIABETES

USPTO (United States) · Serial 79025194

Status
cancelled
Status updated
7 March 2016
Filing date
7 March 2006
Registration date
6 February 2007
Nice classification
16, 42, 44
Owner
Novo Nordisk A/S
Owner country
DK
Raw status code
404

As filed by US

Authoritative source

The official US trademark record is at USPTO TSDR (serial 79025194) ↗. Where our data differs from the USPTO record, theirs is correct.

See methodology for refresh cadence + status normalisation. See sources for licensing.